This is a preview of subscription content, log in via an institution to check access.
Reference
Merkhofer C, et al. Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer. JCO Oncology Practice 17: e1225-e1234, No. 8, Aug 2021. Available from: URL: http://doi.org/10.1200/OP.20.01092
Rights and permissions
About this article
Cite this article
Second-line therapy clinical trial participation cost saving for nSCLC patients in the USA. PharmacoEcon Outcomes News 886, 21 (2021). https://doi.org/10.1007/s40274-021-07999-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-07999-6